Skip to main content
. 2020 May 7;20:157. doi: 10.1186/s12935-020-01238-3

Fig. 9.

Fig. 9

The survival analyses for the low- and high-risk subgroups stratified by clinicopathological parameters in the validation group. a, b The survival analyses for the low- and high-risk subgroups stratified by age; c, d The survival analyses for the low- and high-risk subgroups stratified by gender; e, f The survival analyses for the low- and high-risk subgroups stratified by grade; g, h The survival analyses for the low- and high-risk subgroups stratified by stage